Clinical Trials List
Protocol NumberCOAV101A12306
Completed
2021-09-30 - 2023-08-01
Phase III
Terminated1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Principal Investigator
Yuh-Jyh Jong
Co-Principal Investigator
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2-4 participants
-
Global
24 participants
